ADILNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADIAL PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.62+0.13 (+3.72%)
Close on Oct 19, 2026
- Market cap
- $16.73M
- P/E (TTM)
- –
- Dividend yield
- –
Adial Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $9.51M | $166.30M |
| Enterprise Value | -$19.21M | $88.19M |
Income (trailing twelve months)
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Operating Income | -$57.68M | -$21.40M |
| Net Income | -$57.80M | -$22.46M |
| EBITDA | -$57.68M | -$16.91M |
Returns
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Return on Assets (ROA) | -322.1% | -40.9% |
| Return on Capital Employed (ROCE) | -240.6% | -38.1% |
Balance sheet
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $28.71M | $61.43M |
| Net Cash (Debt) | $28.71M | $15.35M |
| Net Cash Per Share | $10.93 | $0.66 |
| Equity (Book Value) | -$38.38M | $49.09M |
| Book Value Per Share | -$14.61 | $1.37 |
| Tangible Book Value | -$38.38M | $23.52M |
| Working Capital | $23.72M | $76.81M |
Financial position
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 5.63 | 3.34 |
| Quick Ratio | 5.61 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$11.13M | -$12.35M |
Efficiency
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$9.63M | -$703.34K |
| Employee Count | 6 | 74 |
Dividends and yields
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -608.1% | -23.3% |
| Buyback Yield | -17.8% | -0.59% |
| Shareholder Yield | -17.8% | 0.00% |
Shares
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 2,625,890 | 58,127,000 |
| Shares Change (YoY) | 577.6% | 10.9% |
| Shares Change (QoQ) | 74.0% | 0.54% |
| Float | 1,786,260 | 49,136,700 |
| Shares Held by Insiders | 32.0% | 11.6% |
| Shares Held by Institutions | 5.20% | 59.4% |
Scores
| Measure | Adial Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -12.30 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Adial Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.